In:
Eurosurveillance, European Centre for Disease Control and Prevention (ECDC), Vol. 27, No. 48 ( 2022-12-01)
Abstract:
HIV testing was offered to 2,185 people receiving mpox (formerly monkeypox) vaccination, who reported not being HIV positive. Among them 390 were current PrEP users, and 131 had taken PrEP in the past. Of 958 individuals consenting testing, six were newly diagnosed with HIV. Two patients had symptomatic primary HIV infection. None of the six patients had ever taken PrEP. Mpox vaccination represents an important opportunity for HIV testing and counselling about risk reduction and PrEP.
Type of Medium:
Online Resource
ISSN:
1560-7917
DOI:
10.2807/1560-7917.ES.2022.27.48.2200890
Language:
English
Publisher:
European Centre for Disease Control and Prevention (ECDC)
Publication Date:
2022
detail.hit.zdb_id:
2059112-3